de Martino, Michela <br/><br/>
Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.  [electronic resource] 

 -  Cancer biology & therapy  Sep 2014 
 - 1239-47 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.29687  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Humans<br/>In Vitro Techniques<br/>Inhibitory Concentration 50<br/>Lapatinib<br/>Mutation<br/>Quinazolines--pharmacology<br/>Receptor, ErbB-2--genetics<br/>Urinary Bladder Neoplasms--metabolism